Clinical Trials Logo

Pain, Neuropathic clinical trials

View clinical trials related to Pain, Neuropathic.

Filter by:

NCT ID: NCT04781751 Recruiting - Pain, Neuropathic Clinical Trials

Ultrasonographic Insulin Versus Dexamethasone Injection With Local Anestheticss in Diabetic Patients With Mild to Moderate Median Nerve Entrapement Neuropathy .

Start date: February 28, 2021
Phase: N/A
Study type: Interventional

Insulin injection in carpal tunnel compared with dexamethsone in diabetic patients

NCT ID: NCT04737746 Active, not recruiting - Pain, Chronic Clinical Trials

Caregiver Burden and Correlation With Clinical Outcome in Spinal Cord Stimulation for Chronic Neuropathic Pain

CAREstim
Start date: January 18, 2021
Phase:
Study type: Observational [Patient Registry]

Prospective multicentric observational trial on caregiver burden, caregiver satisfaction and clinical outcome in spinal cord stimulation for chronic neuropathic pain.

NCT ID: NCT04721847 Completed - Clinical trials for Diabetic Nephropathy

Pain Neuroscience Education in Diabetic Neuropathy

Start date: August 13, 2020
Phase: N/A
Study type: Interventional

To determine the effects of Pain Neuroscience Education in Diabetic Neuropathy

NCT ID: NCT04718116 Recruiting - Surgery Clinical Trials

Tapentadol Versus Tramadol Analgesia Post Cardiac Surgery

vasso-annie
Start date: November 1, 2022
Phase: N/A
Study type: Interventional

The aim of this randomized one-blinded study will be to evaluate the efficacy and tolerability of two different oral doses of tapentadol and compare it to tramadol (an opioid commonly used to treat post-surgical pain) in cardiac surgery patients

NCT ID: NCT04625504 Completed - Chronic Pain Clinical Trials

Investigating Biological Targets, Markers, and Intervention for Chronic Pain

Start date: November 25, 2020
Phase: N/A
Study type: Interventional

This multi-modal methods study will investigate neurophysiological, endocrinological, cognitive, psycho-social-emotional markers of chronic pain, and therapeutic targets using integrative health treatments.

NCT ID: NCT04622904 Recruiting - Pain, Postoperative Clinical Trials

Lidocaine and Magnesium and Ketamine in Gynecological Surgery

annie-sophia
Start date: November 14, 2020
Phase: N/A
Study type: Interventional

The aim of this study will be to investigate the effect of a combination of intravenous infusions of lidocaine and magnesium versus a combination of intravenous infusions of lidocaine and ketamine versus an intravenous infusion of lidocaine alone on recovery profile, quality of recovery and postoperative pain after elective gynecological surgery

NCT ID: NCT04585620 Not yet recruiting - Chronic Pain Clinical Trials

Botulinum Toxin A as Treatment for Chronic Postsurgical Pain Following Lung Cancer Surgery

Start date: September 1, 2022
Phase: Phase 1/Phase 2
Study type: Interventional

Chronic postsurgical pain following lung cancer surgery is common with and 20-60 % develop chronic pain which persists more than six months after surgery. Causes and health impact of this pain have been comprehensively studied. Current treatment consists of combination of pain medication, physiotherapy and psychological therapy. Botulinum Toxin A (BTX-A) has shown promising effects in a variety of chronic postsurgical pain syndromes. The use of BTX-A in lung cancer patients has only been presented in few case reports. No randomized controlled trials (RCT) have been executed to date. Study objectives: Determine recruitment potential among cured lung cancer patients with chronic postsurgical pain for an RCT and if the method of BTX-A administration is feasible and acceptable. Further more, this study will contribute to the stage testing of the hypothesis that chronic pain following thoracic surgery can be treated with BTX-A. Methods: Recruitment of test subjects: Participiants are recruited among former lung cancer patients with chronic postsurgical pain, who have undergone radical treatment for lung cancer at the Department of Cardiothoracic Surgery, Aalborg University Hospital. Potential test subjects are invited by mail / e-mail. Randomization and blinding: Participants are randomized to receive a single series of subcutaneous injections with either Onabotulinum Toxin A (active agent) or inactive normal saline (Placebo) at the former operation site. Neither participant nor investigator will know which treatment is given until the end of the trial. Data collection: Data is collected by questionnaires delivered and answered by mail or digitally. Data on the possible effects and possible adverse reactions are collected at multiple times until three months after treatment.

NCT ID: NCT04581525 Terminated - Clinical trials for Spinal Cord Injuries

Modulating Neuropathic Pain With Transcranial Direct Current Stimulation

Start date: June 7, 2012
Phase: N/A
Study type: Interventional

This study will examine whether a form of non-invasive brain stimulation can help reduce pain in people with persistent neuropathic pain.

NCT ID: NCT04466826 Withdrawn - Pain, Neuropathic Clinical Trials

Transnasal Sphenopalatine Ganglia Block for Management of Chronic Migraines in Pediatric Patients

Start date: January 2, 2021
Phase: Phase 2
Study type: Interventional

Single-center, open-label, pre-post treatment pilot study to evaluate the safety and effectiveness of sphenopalatine ganglia blocks for the treatment of chronic migraine in the pediatric population. 50 children with a diagnosis of chronic migraines will undergo a series of three transnasal sphenopalatine ganglia blocks to measure their effect on headache frequency, headache intensity, headache duration, and use of headache medication.

NCT ID: NCT04403711 Recruiting - Analgesia Clinical Trials

Dexmedetomidine in TAP Block for Inguinal Hernia Repair

TAP-dex
Start date: April 1, 2018
Phase: N/A
Study type: Interventional

This prospective double-blind randomized study will aim at evaluating the short- and long-term postoperative analgesic efficacy of the ultrasound-guided transversus abdominis plane (TAP) block with a combination of local anesthetic and dexmedetomidine in inguinal hernia repair under general anesthesia